290 related articles for article (PubMed ID: 22177633)
1. Time for a change? Updated guidelines using interferon gamma release assays for detection of latent tuberculosis infection in the office setting.
Kardos M; Kimball AB
J Am Acad Dermatol; 2012 Jan; 66(1):148-52. PubMed ID: 22177633
[TBL] [Abstract][Full Text] [Related]
2. Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors.
Papay P; Primas C; Eser A; Novacek G; Winkler S; Frantal S; Angelberger S; Mikulits A; Dejaco C; Kazemi-Shirazi L; Vogelsang H; Reinisch W
Aliment Pharmacol Ther; 2012 Nov; 36(9):858-65. PubMed ID: 22978645
[TBL] [Abstract][Full Text] [Related]
3. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ release assays for diagnosis of tuberculosis infection and disease in children.
Starke JR;
Pediatrics; 2014 Dec; 134(6):e1763-73. PubMed ID: 25422024
[TBL] [Abstract][Full Text] [Related]
5. Interferon gamma release assays: principles and practice.
Lalvani A; Pareek M
Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
[TBL] [Abstract][Full Text] [Related]
6. A 100 year update on diagnosis of tuberculosis infection.
Lalvani A; Pareek M
Br Med Bull; 2010; 93():69-84. PubMed ID: 19926636
[TBL] [Abstract][Full Text] [Related]
7. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
[TBL] [Abstract][Full Text] [Related]
8. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.
Mariette X; Baron G; Tubach F; Lioté F; Combe B; Miceli-Richard C; Flipo RM; Goupille P; Allez M; Salmon D; Emilie D; Carcelain G; Ravaud P
Ann Rheum Dis; 2012 Nov; 71(11):1783-90. PubMed ID: 22258485
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test.
Laffitte E; Janssens JP; Roux-Lombard P; Thielen AM; Barde C; Marazza G; Panizzon RG; Saurat JH
Br J Dermatol; 2009 Oct; 161(4):797-800. PubMed ID: 19659473
[TBL] [Abstract][Full Text] [Related]
10. Specificity of the tuberculin skin test and the T-SPOT.TB assay among students in a low-tuberculosis incidence setting.
Talbot EA; Harland D; Wieland-Alter W; Burrer S; Adams LV
J Am Coll Health; 2012; 60(1):94-6. PubMed ID: 22171735
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of new and old tests for the diagnosis of latent tuberculosis infection (quantiferon and TST)].
Milotić DM; Popović-Grle S; Katalinić-Janković V; Simunović A
Lijec Vjesn; 2011; 133(11-12):396-402. PubMed ID: 22329296
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new interferon-gamma release assay and comparison to tuberculin skin test during a tuberculosis outbreak.
Song Q; Guo H; Zhong H; Liu Z; Chen X; Wang C; Touzjian N; Lv Y; Lu X; Wang Q
Int J Infect Dis; 2012 Jul; 16(7):e522-6. PubMed ID: 22542006
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an IFN-gamma assay in the diagnosis of latent tuberculosis in patients with psoriasis in a highly endemic setting.
de Andrade Lima E; de Andrade Lima M; de Lorena VM; de Miranda Gomes Y; Lupi O; Benard G
Acta Derm Venereol; 2011 Oct; 91(6):694-7. PubMed ID: 21629971
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
[TBL] [Abstract][Full Text] [Related]
15. Combined use of a TST and the T-SPOT®.TB assay for latent tuberculosis infection diagnosis before anti-TNF-α treatment.
Jung YJ; Lyu J; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee KH; Lee SD; Kim WS; Kim DS; Shim TS
Int J Tuberc Lung Dis; 2012 Oct; 16(10):1300-6. PubMed ID: 22863375
[TBL] [Abstract][Full Text] [Related]
16. Validity of interferon-γ-release assays for the diagnosis of latent tuberculosis in haemodialysis patients.
Chung WK; Zheng ZL; Sung JY; Kim S; Lee HH; Choi SJ; Yang J
Clin Microbiol Infect; 2010 Jul; 16(7):960-5. PubMed ID: 19906274
[TBL] [Abstract][Full Text] [Related]
17. [Interferon-gamma release assays for hospital-based tuberculosis diagnostics in children and adolescents--a retrospective analysis].
Knappik M; Schönfeld N; Günther A; Bergmann T; Magdorf K; Rüssmann H; Mauch H; Barker M
Pneumologie; 2012 Apr; 66(4):207-11. PubMed ID: 22477480
[TBL] [Abstract][Full Text] [Related]
18. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection: an updated review.
Moon HW; Hur M
Ann Clin Lab Sci; 2013; 43(2):221-9. PubMed ID: 23694799
[TBL] [Abstract][Full Text] [Related]
20. Position statement on interferon-γ release assays for the detection of latent tuberculosis infection.
Bastian I; Coulter C;
Commun Dis Intell Q Rep; 2017 Dec; 41(4):E322-E336. PubMed ID: 29864386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
